38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Rimegepant only product in oromucosal dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Satralizumab only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only satralizumab in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only azacitidine in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only azacitidine in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Somapacitan only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only somapacitan in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only clascoterone (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only clascoterone in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Clascoterone 10 mg/g cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Some
Clascoterone 10 mg/g cutaneous cream	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Pralsetinib only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Pralsetinib only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fluoroestradiol (18-F) only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only fluoroestradiol (18-F) in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Fluoroestradiol (18-F) 100 mCi/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Fluoroestradiol (18-F) 100 mCi/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only triheptanoin (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Triheptanoin only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Triheptanoin 960 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Triheptanoin 960 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only remimazolam (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Remimazolam only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Abametapir only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Abametapir only product in cutaneous dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Abametapir 7.4 mg/g cutaneous emulsion	Count of base of active ingredient	False	1	Inferred relationship	Some
Abametapir 7.4 mg/g cutaneous emulsion	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only copper (64-Cu) dotatate (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Copper (64-Cu) dotatate only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Arsenic trioxide 1 mg/mL solution for infusion	Count of base of active ingredient	False	1	Inferred relationship	Some
Arsenic trioxide 1 mg/mL solution for infusion	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Arsenic trioxide 1 mg/mL solution for infusion	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Arsenic trioxide only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Ipilimumab 5 mg/mL solution for infusion	Count of base of active ingredient	False	1	Inferred relationship	Some
Ipilimumab 5 mg/mL solution for infusion	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Idelalisib only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Ceritinib 150 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Ceritinib 150 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product)	Count of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Chondroitin only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Semaglutide 7 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Semaglutide 7 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only coagulation factor VII (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Coagulation factor V only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Hydroxyapatite only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only porcine isophane insulin in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only human isophane insulin in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Hepatitis A virus HM-175 strain antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Live attenuated Human alphaherpesvirus 3 Oka-Merck strain only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Influenza virus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Hepatitis A virus GBM strain antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dulaglutide 1.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dulaglutide 1.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Dulaglutide 3 mg/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Dulaglutide 3 mg/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Dulaglutide 6 mg/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Dulaglutide 6 mg/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Dulaglutide 9 mg/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Dulaglutide 9 mg/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Dulaglutide only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Crisaborole 20 mg/g cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Crisaborole 20 mg/g cutaneous ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Dupilumab 150 mg/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Dupilumab 150 mg/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1

Start Previous Page 214 of 215 End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core